Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Castiglione-Gertsch

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2006
Adjuvant treatment of breast cancer: sequence and duration of hormonal therapyM Castiglione-Gertsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Hormone replacement and breast cancerM Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
New aromatase inhibitors: more selectivity, less toxicity, unfortunately, the same activityM Castiglione-Gertsch
Helvetica Chirurgica Acta|May 1, 1992
[Local recurrence of breast cancer: prognostic factors, effect of adjuvant therapy]M Castiglione-Gertsch
Archives of Gynecology and Obstetrics|October 4, 2016
A Goldhirsch, M Castiglione-Gertsch
Archives of Gynecology and Obstetrics|January 1, 1995
-Adjuvant systemic therapy of breast carcinoma-A Goldhirsch, M Castiglione-Gertsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian cancer: are we ready to go?S Aebi, M Castiglione-Gertsch
Minerva Ginecologica|November 28, 2009
Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancerC K Baumann, M Castiglione-Gertsch
Therapeutische Umschau. Revue Therapeutique|November 1, 1996
[Questions and answers on adjuvant systemic therapy in breast carcinoma]M F Fey, M Castiglione-Gertsch
Therapeutische Umschau. Revue Therapeutique|June 1, 1988
[Adjuvant therapy following breast-sparing surgery of breast carcinoma: priority to chemo- or radiotherapy?]A Goldhirsch, M Castiglione-Gertsch, H Neuenschwander
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 5, 2006
Adjuvant treatment of breast cancer: sequence and duration of hormonal therapyM Castiglione-Gertsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 13, 2004
Hormone replacement and breast cancerM Castiglione-Gertsch
European Journal of Cancer (Oxford, England : 1990)|March 1, 1996
New aromatase inhibitors: more selectivity, less toxicity, unfortunately, the same activityM Castiglione-Gertsch
Helvetica Chirurgica Acta|May 1, 1992
[Local recurrence of breast cancer: prognostic factors, effect of adjuvant therapy]M Castiglione-Gertsch
Archives of Gynecology and Obstetrics|October 4, 2016
A Goldhirsch, M Castiglione-Gertsch
Archives of Gynecology and Obstetrics|January 1, 1995
-Adjuvant systemic therapy of breast carcinoma-A Goldhirsch, M Castiglione-Gertsch
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
High-dose chemotherapy for ovarian cancer: are we ready to go?S Aebi, M Castiglione-Gertsch
Minerva Ginecologica|November 28, 2009
Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancerC K Baumann, M Castiglione-Gertsch
Therapeutische Umschau. Revue Therapeutique|November 1, 1996
[Questions and answers on adjuvant systemic therapy in breast carcinoma]M F Fey, M Castiglione-Gertsch
Therapeutische Umschau. Revue Therapeutique|June 1, 1988
[Adjuvant therapy following breast-sparing surgery of breast carcinoma: priority to chemo- or radiotherapy?]A Goldhirsch, M Castiglione-Gertsch, H Neuenschwander
Pageof 7